Integrating analysis of circular RNA and mRNA expression profiles in doxorubicin induced cardiotoxicity mice
Related Experiment Video
Updated: Oct 15, 2025

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
Xiaoqing Xing1, Zhenzhen Tan2, Xuran Zhi1
1Department of Pharmacy, Hebei General Hospital, Shijiazhuang, China.
Abstract:
Doxorubicin (DOX)-induced cardiotoxicity impedes its clinical application, but the mechanisms have not been thoroughly elucidated. Based on circRNA and mRNA expression profiles, we illustrated RNA expression signature changes during DOX-induced cardiotoxicity; mechanism exploration and biomarkers screening were also conducted. Twelve mice were randomly divided into two groups, induction group was treated with doxorubicin, and the control group was given an equal quantity of saline. After the confirmation of myocardial injury in induction group, the heart tissues from both groups were isolated for RNA high-throughput sequencing. The expression profiles were compared between the two groups; a total of 295 mRNAs and 11 circRNAs were shown as biased expression in DOX-induced cardiotoxicity mouse hearts. The dysregulation of three circRNAs were validated by quantitative real-time PCR: mmu_circ_0015773, mmu_circ_0002106, and mmu_circ_001606. In addition, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses of the differentially expressed RNAs were performed; the results implied that DOX might cause cardiotoxicity by interfering hemoglobin-based oxygen delivery and DNA-associated signal pathways. We integrated the differential expressed mRNA and validated circRNAs by constructing a competing endogenous RNA (ceRNA) network, which indicated that the alteration of the three circRNAs could activate apoptosis process of myocardial cells. This study provided novel insight into the mechanisms of DOX induced cardiotoxicity, and potential biomarkers or therapeutic targets were also proposed.
Insights
Doxorubicin (DOX) causes heart damage by altering RNA expression, potentially through oxygen delivery and DNA pathways. Three specific circRNAs were identified as key players in DOX-induced cardiotoxicity.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Genomics
Background:
- Doxorubicin (DOX) is a vital chemotherapy agent, but its clinical use is limited by cardiotoxicity.
- The precise molecular mechanisms underlying DOX-induced cardiotoxicity remain incompletely understood.
- Identifying novel biomarkers and therapeutic targets is crucial for mitigating DOX's adverse cardiac effects.
Purpose of the Study:
- To investigate the RNA expression signature changes in DOX-induced cardiotoxicity.
- To explore the underlying molecular mechanisms and identify potential biomarkers.
- To construct a competing endogenous RNA (ceRNA) network for mechanistic insights.
Main Methods:
- RNA high-throughput sequencing was performed on heart tissues from DOX-treated and control mice.
- Differential expression analysis identified significant changes in mRNA and circRNA levels.
- Quantitative real-time PCR validated dysregulated circRNAs; Gene Ontology and KEGG pathway analyses were conducted.
Main Results:
- A total of 295 mRNAs and 11 circRNAs showed biased expression in DOX-induced cardiotoxicity.
- Three circRNAs (mmu_circ_0015773, mmu_circ_0002106, mmu_circ_001606) were validated.
- Pathway analyses suggested DOX interferes with oxygen delivery and DNA signaling, potentially activating myocardial cell apoptosis via the ceRNA network.
Conclusions:
- DOX-induced cardiotoxicity involves significant alterations in circRNA and mRNA expression.
- Specific circRNAs (mmu_circ_0015773, mmu_circ_0002106, mmu_circ_001606) are implicated in the cardiotoxic mechanism.
- This study offers potential biomarkers and therapeutic targets for DOX cardiotoxicity.

